In mammary adenocarcinoma (SKBr-3) EGFR (2.2 × 105/cell) is over-expressed and HER2/neu (1 × 106/cell) is highly over-expressed compared to normal/healthy tissues and organ systems. This evidence concerns the gene ERBB2 and breast adenocarcinoma.